Garban Hermes de Jesus 4
4 · Vincerx Pharma, Inc. · Filed Mar 3, 2021
Insider Transaction Report
Form 4
Garban Hermes de Jesus
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2021-03-01+150,000→ 150,000 totalExercise: $19.24Exp: 2031-03-01→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]Option vests over three years, with 1/3 of the shares vesting on March 1, 2022, and 1/36th of the shares vesting monthly after March 1, 2021.